Physician profile
Kari E Sower
NPI 1821443235
$1,281.34
in general payments reported to CMS, 2019-2025
17 companies · $75.10 in 2025
The $75.10 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $313 · 2022: $161 · 2023: $470 · 2024: $262 · 2025: $75.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $527.64 | 2021-2025 | |
| Astellas Pharma US INC | $91.74 | 2023-2024 | Veozah |
| Shield Therapeutics INC | $83.98 | 2024 | |
| Pfizer INC. | $83.72 | 2022-2023 | |
| Therapeuticsmd, INC. | $75.29 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $71.91 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.06 | 2023-2024 | |
| Organon LLC | $42.92 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $38.23 | 2023-2024 | Myfembree |
| Merck Sharp & Dohme LLC | $36.39 | 2021 | |
| Evofem Biosciences, INC. | $35.64 | 2021 | |
| Daiichi Sankyo INC. | $31.80 | 2021 | |
| Coopersurgical, INC. | $30.78 | 2022-2023 | Paragard T 380a |
| Hologic Sales and Service, LLC | $24.81 | 2025 | Aptima |
| Myovant Sciences INC. | $21.33 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $16.55 | 2024 | Zurzuvae |
| Avion Pharmaceuticals | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Sower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.